High-throughput isn’t just for big pharma anymore. What used to be the domain of large pharmaceutical companies and centralized core facilities is now increasingly accessible to smaller biotech companies, diagnostic labs, and research institutions.
Thanks to advances in lab automation, modular hardware, and more flexible procurement strategies, even lean teams can implement high-throughput workflows that rival traditional industrial setups.
And the payoff is real: faster turnaround times, higher reproducibility, reduced manual error, and more efficient use of reagents and personnel. Whether you're optimizing an existing process or designing a new one from scratch, high-throughput systems can help you scale without overextending your team.
The challenge? The lab equipment that powers high-throughput screening—liquid handlers, automated incubators, robotic workstations—can be costly to acquire and maintain. That’s where leasing enters the conversation.
In this article, we’ll explore how to modernize and scale your workflows through automation—and how leasing can make high-throughput systems more accessible, cost-effective, and adaptable for growing labs.
If you're still relying on manual protocols or partially automated steps, you're not alone—but you might be missing out. Transitioning to high-throughput workflows isn’t just about speed; it’s about building a more scalable, reliable, and future-ready lab.
Manual pipetting, plate handling, and sample prep steps are time-consuming and prone to mistakes. Even minor inconsistencies in liquid handling or incubation times can affect assay results, delay projects, or compromise quality control. Automating these steps dramatically improves reproducibility and minimizes variability between runs.
Automated workflows allow you to process more samples in less time without requiring additional staff. That’s a major benefit for labs with lean teams or tight hiring budgets—especially in biotech and diagnostics, where every delay can affect downstream timelines.
By integrating high-throughput systems into your workflow, you can run more assays in parallel, reduce downtime between steps, and optimize sample preparation. This means faster data generation, quicker decision-making, and a stronger ability to meet research or clinical deadlines.
High-throughput automation is also more precise. With accurate dispensing and controlled timing, you reduce reagent waste and get more consistent results per run. Over time, that efficiency translates to meaningful cost savings.
Upgrading your workflow doesn’t mean overhauling everything at once. Even incremental automation—like introducing a benchtop liquid handler or automated PCR setup—can make a measurable difference in lab productivity and data quality.
Building a high-throughput workflow doesn’t require a massive footprint—but it does require the right tools. From sample prep to data readout, these are the systems that enable labs to automate at scale and streamline operations across the board.
Automated liquid handlers and robotic pipetting platforms are foundational to high-throughput workflows. They improve precision, reduce contamination risk, and dramatically speed up protocols involving multiwell plates, serial dilutions, and assay setup.
These modular systems can automate entire workflows, handling tasks like plate movement, incubation, reagent addition, and more. Ideal for high-throughput screening and repetitive workflows, they support long unattended run times and consistent results.
Whether you're working in drug discovery or diagnostics, high-throughput data capture is critical. Multi-mode plate readers and real-time PCR systems allow rapid measurement of absorbance, fluorescence, luminescence, and gene expression—without manual data handling.
Temperature control and centrifugation are essential for many workflows, and automating these steps helps reduce manual steps and improve timing consistency. Many newer systems are designed for integration with robotic arms or scheduling software.
Together, these systems form the backbone of modern high-throughput workflows. But acquiring them all at once can be a financial hurdle—especially for startups or smaller labs. That’s where leasing becomes an enabler, not just an alternative.
High-throughput systems offer major gains in speed and scalability—but they’re also some of the most capital-intensive equipment on the market. For many labs, leasing provides a way to adopt automation without overextending budgets or delaying implementation.
Leasing enables labs to move faster and smarter—bringing high-throughput capabilities online without the financial drag that often comes with traditional procurement.
High-throughput success isn’t just about having the right tools—it’s about being able to adapt as needs evolve. Leasing supports that adaptability by giving labs more freedom to experiment, expand, and optimize without being locked into rigid infrastructure or outdated systems.
Whether you're scaling up for a new drug discovery screen or launching a diagnostic assay, leasing allows you to expand capacity without permanently increasing fixed assets. You can lease additional instruments as needed—then scale back if project volume decreases.
Scientific workflows don’t stand still. As reagents, sample types, and assay formats change, the systems you need may shift too. Leasing enables you to pivot more easily—swapping in new platforms or configurations without needing to justify capital expenditure all over again.
Modern workflows rely on seamless data capture and management. Leasing allows you to adopt LIMS-compatible, cloud-integrated, or software-upgradable systems that work in real time with your lab’s broader infrastructure—without needing a long-term commitment to any single platform.
Most importantly, leasing allows labs to optimize the end-to-end workflow—not just individual pieces of equipment. You can design around your science, rather than letting procurement constraints dictate what’s possible.
When your lab’s performance depends on speed, reproducibility, and adaptability, flexibility isn’t a luxury—it’s a requirement.
High-throughput workflows are no longer a luxury reserved for global pharma companies. They’re becoming a critical capability for biotech startups, diagnostic labs, and research institutions that need to move faster, deliver high-quality data, and scale without bottlenecks.
Automation offers a powerful path forward—but the barrier has often been cost, not ambition. Leasing helps remove that barrier, giving labs access to the high-throughput systems they need while preserving budget flexibility and reducing risk. Whether you're automating pipetting, accelerating screening, or tightening up your quality control, leasing can help you:
Ultimately, the goal is to build workflows that are faster, more reproducible, and ready to support real-world research and development needs. With the right systems—and the right procurement strategy—you can turn automation into a competitive advantage.
Ready to bring high-throughput automation into your lab without the upfront cost?
Excedr helps biotech and life sciences teams lease the systems they need—from liquid handlers to plate readers—so they can scale faster, improve reproducibility, and stay focused on what matters most: generating high-quality data.